In an overwhelming vote, an advisory panel has recommended that the Food and Drug Administration impose strict new limitations on so-called Low T drugs so that they are reserved for men with specific medical conditions and not merely those with signs of normal aging.
The expert panel also recommended that more safety studies be conducted to assess potential cardiovascular risks associated with low testosterone replacement therapies.
The FDA doesn’t have to move on the recommendation of the panel, but it often does so.
In January, the FDA announced it was reviewing the safety of testosterone replacement drugs based on two studies that showed so-called Low T drugs greatly increased the risks of severe cardiovascular events in older men.
Among other things, the panel is urging the FDA to tighten labeling on all testosterone replacement drugs in hopes of limiting prescriptions to men with serious medical conditions, such as pituitary gland problems.
The use of testosterone replacement drugs has quadrupled since the early 2000s as more and more men are turning to the treatments based on marketing suggesting they increase energy and sex drive.
Ross Feller Casey, a top personal injury law firm with a national reputation, has already filed a series of testosterone lawsuits. The Low T lawyers at Ross Feller Casey are currently reviewing many other injuries and plan to bring other testosterone lawsuits soon.
If you or a loved one has suffered serious medical events after taking testosterone drugs, please contact the testosterone attorneys at Ross Feller Casey for a free case review.
To learn more, go to www.rossfellercasey.com/practice-areas/lowtlawsuit/